At Iris Pharma, we have decades of experience in performing comprehensive clinical research and development in all areas of ophthalmology. This has allowed us to build a network of experienced investigative sites and scientists in each eye disease and condition to support efficient patient recruitment.
During the clinical development process, we take into account a drug or device’s future use and anticipate possible risks, to facilitate and accelerate New Drug Applications (NDA) and Marketing Authorization Applications (MAA).
KEY FIGURE: 125 clinical trials in ophthalmology performed
